![[Search]](/static/images/search.gif){kind=small}
![[A-Z Index]](/static/images/az.gif){kind=small}
![[Contact]](/static/images/contact.gif){kind=small}
![[University of Cambridge]](/static/images/identifier2.gif){kind=small}
![[Talks.cam]](/static/images/talkslogosmall.gif)
Dr Darrin Disley, (1991-96 PhD Biotechnology), Executive Chairman of Horizon Discovery Ltd and Director of New Ventures of Execute Technologies
Friday 26 November 2010, 17:00-18:00
Introducing X-MAN – The Model Cancer Patient
- 👤 Speaker: Dr Darrin Disley, (1991-96 PhD Biotechnology), Executive Chairman of Horizon Discovery Ltd and Director of New Ventures of Execute Technologies
- 📅 Date & Time: Friday 26 November 2010, 17:00 - 18:00
- 📍 Venue: Dept Chemical Engineering and Biotechnology, New Museums Site, Pembroke Street, CB2 3RA
Abstract
This proprietary virally-mediated human gene-editing technology enables any endogenous gene in a human cell-line to be altered quickly, reliably and without introducing unwanted and confounding genotypes and/or phenotypes. X-MAN cell lines accurately model the disease-causing mutations observed in cancer patients and are being used by academic and industry leaders to identify the effect of individual mutations on drug activity, patient responsiveness and resistance, and to successfully predict which patient sub-groups will respond to currently-available and future drug treatments. The findings from the company’s scientific founders and advisors are defining how targeted colorectal cancer drugs are developed and prescribed.
Series This talk is part of the CEB Alumni Speaker Series series.
Included in Lists
- All Talks (aka the CURE list)
- CamBridgeSens
- Cambridge talks
- CEB Alumni Speaker Series
- Chemical Engineering and Biotechnology
- Dept Chemical Engineering and Biotechnology, New Museums Site, Pembroke Street, CB2 3RA
- Featured lists
- ME Seminar
- School of Technology
- Trust & Technology Initiative - interesting events
- yk449
Note: Ex-directory lists are not shown.